Oliver Loewenstein

Suggest Changes
Learn More
BACKGROUND Two randomised 12-week, double-blind, parallel-group, multicenter studies comparing oxycodone PR/naloxone PR and oxycodone PR alone on symptoms of opioid-induced bowel dysfunction in(More)
  • 1